Activities per year
Abstract
Alterations throughout the androgen receptor (AR) gene influence male reproductive development and function and are associated with androgen insensitivity syndrome (AIS), a disease with a prominent genotypic-phenotypic heterogeneity.
We determined the AR gene sequence in 21 patients. Ten patients were suspicious of AIS. 4/6 with known 46,XY karyotype had complete AIS (CAIS) and 1/6 had premature amenorrhea. The presence of an Y-chromosome was confirmed in 2 patients by AR-MLPA, whereas karyotypes remained unknown for 2 AIS patients.
Three nonsense mutations were discovered at codons 353, 829 and 831 respectively, and a 4bp duplication c.2227_2230dupATGG were found to induce a premature stopcodon at codon 769. Two missense mutations at codon 700 and 860 were detected within the AR ligand binding domain. Suspicion of AR-gene or -exon deletion in 2 patients, was corroborated by AR-MLPA, demonstrating the importance of confirmation methodology. For the remaining 6 patients (few clinical and/or karyotype information was available and) no AR-alterations were found. Carrier status was confirmed in 5 investigated relatives of some of the index cases.
Our study has revealed a number of previously undescribed amino acid alterations presumingly causing impairment of the AR protein function.
Our findings demonstrate that AR sequencing and MLPA are important tools to support the clinical diagnosis and counseling of AIS. Moreover, the AIS genetic testing may be used for prenatal diagnosis and pre-implantation genetic diagnosis, for which the CAG-repeat in exon 1 can be used as marker.
We determined the AR gene sequence in 21 patients. Ten patients were suspicious of AIS. 4/6 with known 46,XY karyotype had complete AIS (CAIS) and 1/6 had premature amenorrhea. The presence of an Y-chromosome was confirmed in 2 patients by AR-MLPA, whereas karyotypes remained unknown for 2 AIS patients.
Three nonsense mutations were discovered at codons 353, 829 and 831 respectively, and a 4bp duplication c.2227_2230dupATGG were found to induce a premature stopcodon at codon 769. Two missense mutations at codon 700 and 860 were detected within the AR ligand binding domain. Suspicion of AR-gene or -exon deletion in 2 patients, was corroborated by AR-MLPA, demonstrating the importance of confirmation methodology. For the remaining 6 patients (few clinical and/or karyotype information was available and) no AR-alterations were found. Carrier status was confirmed in 5 investigated relatives of some of the index cases.
Our study has revealed a number of previously undescribed amino acid alterations presumingly causing impairment of the AR protein function.
Our findings demonstrate that AR sequencing and MLPA are important tools to support the clinical diagnosis and counseling of AIS. Moreover, the AIS genetic testing may be used for prenatal diagnosis and pre-implantation genetic diagnosis, for which the CAG-repeat in exon 1 can be used as marker.
Original language | English |
---|---|
Pages (from-to) | 312-312 |
Number of pages | 1 |
Journal | Eur J Hum Genet |
Volume | 17 |
Publication status | Published - 23 May 2009 |
Event | European Human Genetics Conference 2009 - Vienna, Austria Duration: 23 May 2009 → 26 May 2009 |
Keywords
- androgen receptor
- AIS
- genetic diagnosis
Fingerprint
Dive into the research topics of 'Molecular spectrum of androgen receptor gene alterations in Belgian patients.'. Together they form a unique fingerprint.Activities
- 1 Participation in conference
-
European Society of Human Genetics, 40th Meeting.
Sara Seneca (Participant)
23 May 2009 → 26 May 2009Activity: Participating in or organising an event › Participation in conference